As More Americans Embrace Anxiety Treatment, MAHA Derides Medications
After a grueling year of chemotherapy, surgery, and radiation to treat breast cancer, Sadia Zapp…
After a grueling year of chemotherapy, surgery, and radiation to treat breast cancer, Sadia Zapp was anxious — not the manageable hum that had long been part of her life, but something deeper, more distracting. “Every little ache, like my knee hurts,” she said, made her worry that “this is the end of the road…
When Lisa Bonfield gave birth to daughter Adele in late November, she was thrust into the new world of parenting, and faced an onslaught of challenges and skills to learn: breastfeeding, diapering, sleep routines, colic, crying, and all the little warning signs that something could be wrong with the baby. But unlike parents in most…
As hundreds of rural hospitals face the risk of closure, healthcare leaders warn that the fallout extends far beyond patient outcomes. During a panel at ViVE in Los Angeles, healthcare leaders outlined how access to care underpins the economic stability of rural America. The post The Rural Care Crisis Is an Economic Issue, Not Just…
Experts say Hims & Hers’ acquisition of Eucalyptus positions the company for global expansion and revenue diversification amid U.S. GLP-1 regulatory challenges. The post What Experts Say About Hims & Hers’ $1.15B Acquisition of Eucalyptus appeared first on MedCity News.
At the end of the day, it doesn’t matter what your patient mix looks like; your notes can and will be pulled into audits. Waiting until CMS is at your doorstep isn’t a strategy — it’s a risk. Now is the moment to get ahead of it. The post Why Providers Can’t Ignore CMS Audits…
Korsana Biosciences’ preclinical Alzheimer’s disease drug comes from a platform technology that enables antibodies to cross the blood-brain barrier. Roche and AbbVie have clinical-stage drugs taking a similar approach to Alzheimer’s. The post Startup Korsana Bio Reveals $175M Raised for a Better Brain-Penetrating Alzheimer’s Drug appeared first on MedCity News.
Shalin Shah, CEO of Marius Pharmaceuticals, which makes an oral testosterone replacement drug, thinks TRT therapy should no longer be regulated as a controlled substance The post MedCity Pivot Podcast: Should Testosterone Replacement Therapy Be Less Regulated? appeared first on MedCity News.
Early experience and comfort with AI benefits everyone. Nurses who understand how to work alongside technology are better equipped to deliver high-quality care, adapt to new systems, and navigate increasingly complex clinical environments. The post AI is Changing Nursing Education and Raising New Graduate Expectations appeared first on MedCity News.
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed on CBS News 24/7’s The Daily Report on Feb. 16 how the recent deaths of two actors sparked searches for colorectal cancer information. Click here to watch Gounder on The Daily Report. KFF Health News Southern correspondent Sam Whitehead discussed on WUGA’s The Georgia Health…
Since adopting Arintra’s AI platform for medical coding in 2023, Mercyhealth has seen a 5.1% rise in revenue and a 50% decline in its days in accounts receivable. The AI-powered platform automates coding, spots documentation gaps and generates claims tailored to specific payers. The post How Arintra’s Coding AI Helped Mercyhealth Boost Revenue by 5%…